Veracyte (VCYT) Form 4: CAO awarded 2,886 RSUs; holdings 49,665
Veracyte, Inc. (VCYT) officer Jonathan Wygant, VP and Chief Accounting Officer, reported an equity award on Form 4.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Veracyte, Inc. (VCYT) officer Jonathan Wygant, VP and Chief Accounting Officer, reported an equity award on Form 4. On 10/28/2025, he acquired 2,886 shares of common stock at $0 under transaction code A, reflecting a restricted stock unit grant. Following the transaction, his beneficial ownership stands at 49,665 shares, held directly.
The filing notes the RSUs were awarded on October 28, 2025 and vest in full on the first anniversary of the grant date, subject to his continued employment.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 2,886 | $0.00 | $0.00 |
Footnotes (1)
- F1. Restricted stock units awarded on October 28, 2025 vest in full on the first anniversary of the grant date subject to continuing employment of the Reporting Person.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Veracyte (VCYT) disclose in this Form 4?
Who is the reporting person in the VCYT Form 4?
What is the vesting schedule for these RSUs at Veracyte (VCYT)?
What type of security was reported in Veracyte’s Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.